Key statistics
On Monday, Cabaletta Bio Inc (CABA:NSQ) closed at 3.30, -12.70% below its 52-week high of 3.78, set on Feb 25, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 3.13 |
|---|---|
| High | 3.38 |
| Low | 3.13 |
| Bid | 3.21 |
| Offer | 3.34 |
| Previous close | 3.32 |
| Average volume | 3.66m |
|---|---|
| Shares outstanding | 96.27m |
| Free float | 94.75m |
| P/E (TTM) | -- |
| Market cap | 319.60m USD |
| EPS (TTM) | -2.51 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
- Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
- Cabaletta Bio Announces 2026 Strategic Priorities
- Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
- Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December
- Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025
- Cabaletta Bio Announces Appointment of Steve Gavel as Chief Commercial Officer and Award of Inducement Grant
- Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
- Cabaletta Bio to Participate in Upcoming Investor Conferences in September
- Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
More ▼
